• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Access to Healthcare / India introduces pneumonia vaccine

India introduces pneumonia vaccine

June 30, 2017 By Nicholas Parry Leave a Comment

India currently holds the highest burden of child deaths due to pneumonia in the world. Pneumonia kills more children under five years old in India than any other disease. This accounts for 20 percent of child mortalities globally. In India, this amounts to around 944,000 child deaths a year (based on data from 2015). The disease is however entirely preventable, yet until recently there was no government programme to ensure that all available  vaccinations were in place to attempt to reduce infant mortality.

Copyright: <a href='https://www.123rf.com/profile_p6m5'>p6m5 / 123RF Stock Photo</a>
Phlegm in the lungs can cause severe respiratory issues during a pneumonia infection

Pneumococcal conjugate vaccine (PCV) was added to the Universal Immunisation Programme (UIP) as of May 13th. J P Nadda, Union Minister for Health and Family Welfare said on the matter “No child should die in the country from Vaccine-Preventable Diseases“.

Nadda adds that this vaccination has been available in the private sector in India for years. While this has meant that the vaccine was potentially accessible, it was off limits to those who could not afford it. He goes on to say “by making them available under the UIP, the government is ensuring equitable access to those who need them the most, the underprivileged and underserved,”

The question is, why has India been so slow. PCV is already available in many African countries that are far poorer than India. How can Burkina Faso and the Central African Republic manage something that India cannot? Some suspect that the Government has been tempted to wait by promises from Indian manufacturers that they would soon have rival PCV vaccines. Despite the promises, and large chunks of Gates funding none have yet succeeded.

Current plans for the first phase of the belated rollout of the vaccine involve the distribution to 21 lakh children (2.1 million) in Himachal Pradesh and parts of Bihar and Uttar Pradesh. In 2018 the aim is to expand the programme to Madhya Pradesh and Rajasthan, followed by implementation of the plan at a national level in a phase by phase manner.

The vaccine itself, the 13-valent pneumococcal conjugate vaccine (PCV-13), produced by Pfizer, is the most widely used pneumococcal vaccine in the world. Aside from pneumonia, the vaccination protects against pneumococcal bacteremia as well as the potentially lethal pneumococcal meningitis.

The vaccine has been shown in studies to be highly effective, with a coverage rate following vaccination of 86 percent after a single dose. Multiple doses were shown to be more effective, raising the effectiveness to 91 percent.

India takes the highest place in terms of child deaths due to pneumonia, followed by Nigeria, Pakistan, Democratic Republic of Congo and Angola. It is hoped that with the UIP programme taking effect, as well as gradually implementing more vaccines into the programme India will steer away from its track record of child mortality.

Despite the currently grave situation, progress is positive. The number of vaccinations counted as part of the programme has grown since it was introduced, and the focus seems to be on ensuring a healthy younger generation. Naddu commented “Strengthening routine immunisation is an essential investment in India’s children and will ensure a healthy future of the country.”

 

Filed Under: Access to Healthcare, Featured, Medicine and Research, National, News Tagged With: pneumonia, vaccine

About Nicholas Parry

Nicholas Parry has a Bachelor of Science in genetics from the University of Sheffield and a Master of Research in neuroscience from the University of Nottingham. He has been a featured writer for Health Issues since 2016. He is based in South Wales.

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.